Glucagon‐like peptide‐1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta‐analysis of observational studies

Ähnliche Einträge

• The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
  von: Iskandar Idris
  Veröffentlicht: (2024)
• Glucagon‐like peptide‐1 receptor agonists and mental health: A meta‐analysis of randomized controlled trials
  von: Giovanni Antonio Silverii, et al.
  Veröffentlicht: (2024)
• Glucagon‐like peptide ‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysis
  von: Muhammad Aaqib Shamim, et al.
  Veröffentlicht: (2024)
• Glucagon‐like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed?
  von: Dario Giugliano, et al.
  Veröffentlicht: (2025)
• Glucagon‐like peptide‐1 receptor agonists lower risk of cardiovascular and non‐cardiovascular mortality: A meta‐analysis of eleven cardiovascular outcome trials
  von: Yu Mi Kang, et al.
  Veröffentlicht: (2025)